|
 |
European Biopharmaceutical Review
|
| In the midst of war, these are uncertain times to be going about the daily business of biotech with stock markets initially surging on the news and then reacting unpredictably to specific developments in the conflict. Given the consistently poor market conditions over the last two years, many of the smaller private companies will probably not see much difference in terms of the environment. There is still next to no short-term scope to access funding via the public markets, which continue to exert downward pressure on valuation of private companies, and maintain the high-level scrutiny by venture capital investors in private funding rounds. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
BioPh Europe
5-7 October 2010, Paris, France
All companies and organisations dealing with the research and development of new treatment methods made through biotechnological processes or which are derived from or use live organisms will benefit from the mix of exhibition, seminars and 121 partnering meetings at BioPh. BioPh Europe 2010 at Paris Nord Villepinte will offer you unrivalled networking and commercial opportunities in the world of drug research and manufacturing.
More info >> |
|
 |
News and Press Releases |
 |
PharmaBrand Summit 2010
Top pharmaceutical executives shared best practices at the PharmaBrand Summit
2010, which took place on the 21st to 23rd June 2010 in Monte-Carlo, Monaco
and was organised by Marcus Evans
More info >> |
|
  |
